ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for CGEM

Stock NameCullinan Oncology LLC
TickerCGEM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS2300311063

Show aggregate CGEM holdings

News associated with CGEM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages
Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025
(RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc
Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80
Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP
ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.
American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says
Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56

iShares MSCI World Small Cap UCITS ETF USD (Acc) CGEM holdings

DateNumber of CGEM Shares HeldBase Market Value of CGEM SharesLocal Market Value of CGEM SharesChange in CGEM Shares HeldChange in CGEM Base ValueCurrent Price per CGEM Share HeldPrevious Price per CGEM Share Held
2026-01-13 (Tuesday)30,938USD 331,965CGEM holding increased by 3713USD 331,9650USD 3,713 USD 10.73 USD 10.61
2026-01-12 (Monday)30,938USD 328,252CGEM holding decreased by -8972USD 328,2520USD -8,972 USD 10.61 USD 10.9
2026-01-09 (Friday)30,938USD 337,224CGEM holding decreased by -7425USD 337,2240USD -7,425 USD 10.9 USD 11.14
2026-01-08 (Thursday)30,938CGEM holding increased by 67USD 344,649CGEM holding increased by 6920USD 344,64967USD 6,920 USD 11.14 USD 10.94
2026-01-07 (Wednesday)30,871USD 337,729CGEM holding increased by 24080USD 337,7290USD 24,080 USD 10.94 USD 10.16
2026-01-06 (Tuesday)30,871USD 313,649CGEM holding increased by 5248USD 313,6490USD 5,248 USD 10.16 USD 9.98999
2026-01-05 (Monday)30,871USD 308,401CGEM holding decreased by -4014USD 308,4010USD -4,014 USD 9.98999 USD 10.12
2026-01-02 (Friday)30,871USD 312,415CGEM holding decreased by -7100USD 312,4150USD -7,100 USD 10.12 USD 10.35
2025-12-31 (Wednesday)30,871USD 319,515CGEM holding increased by 13275USD 319,5150USD 13,275 USD 10.35 USD 9.91999
2025-12-30 (Tuesday)30,871USD 306,240CGEM holding decreased by -6792USD 306,2400USD -6,792 USD 9.91999 USD 10.14
2025-12-29 (Monday)30,871USD 313,032CGEM holding decreased by -7100USD 313,0320USD -7,100 USD 10.14 USD 10.37
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGEM by Blackrock for IE00BF4RFH31

Show aggregate share trades of CGEM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-08BUY6711.44010.602 10.686USD 716 9.88
2025-12-16BUY20411.23010.075 10.190USD 2,079 9.86
2025-12-12BUY33512.94011.900 12.004USD 4,021 9.85
2025-12-01SELL-91011.38510.400 10.498USD -9,554 9.78 Loss of -650 on sale
2025-11-26SELL-6512.20011.435 11.511USD -748 9.76 Loss of -114 on sale
2025-11-26SELL-6512.20011.435 11.511USD -748 9.76 Loss of -114 on sale
2025-11-20BUY2079.2908.530 8.606USD 1,781 9.74
2025-11-19BUY2,0408.7308.230 8.280USD 16,891 9.75
2025-11-14SELL-2768.8357.930 8.020USD -2,214 9.76 Profit of 481 on sale
2025-10-29BUY1367.6908.570 8.482USD 1,154 9.89
2025-10-21BUY2728.4808.690 8.669USD 2,358 9.95
2025-10-07BUY1365.8905.980 5.971USD 812 9.99
2025-09-08SELL-2726.8407.090 7.065USD -1,922 10.20 Profit of 851 on sale
2025-08-15BUY1367.6607.810 7.795USD 1,060 10.21
2025-07-14BUY2727.8707.880 7.879USD 2,143 10.32
2025-06-30BUY2727.5308.000 7.953USD 2,163 10.44
2025-06-25BUY4027.9208.000 7.992USD 3,213 10.47
2025-06-20SELL-677.6708.180 8.129USD -545 10.53 Profit of 161 on sale
2025-06-12SELL-5448.9509.060 9.049USD -4,923 10.61 Profit of 851 on sale
2025-06-02BUY2048.7509.120 9.083USD 1,853 10.71
2025-05-28BUY1367.8407.940 7.930USD 1,078 10.76
2025-05-14BUY677.1307.780 7.715USD 517 11.01
2025-05-13BUY1347.6208.090 8.043USD 1,078 11.04
2025-05-07BUY2017.7007.920 7.898USD 1,587 11.15
2025-04-28BUY677.7558.305 8.250USD 553 11.33
2025-04-16BUY8717.6107.785 7.767USD 6,765 11.58
2025-04-14BUY1347.7407.970 7.947USD 1,065 11.65
2025-04-08SELL-1347.3207.830 7.779USD -1,042 11.82 Profit of 541 on sale
2025-04-04SELL-1347.4107.615 7.594USD -1,018 11.91 Profit of 578 on sale
2025-03-28BUY6708.0208.320 8.290USD 5,554 12.09
2025-03-12SELL-1349.0809.190 9.179USD -1,230 12.60 Profit of 458 on sale
2025-03-04SELL-1348.1308.315 8.296USD -1,112 12.87 Profit of 613 on sale
2025-02-26SELL-2688.4508.705 8.679USD -2,326 13.12 Profit of 1,191 on sale
2025-02-13BUY679.5909.960 9.923USD 665 13.68
2025-02-12BUY2689.8909.950 9.944USD 2,665 13.74
2025-01-27BUY6710.30010.880 10.822USD 725 14.55
2025-01-23BUY6710.56010.600 10.596USD 710 14.72
2024-12-09BUY2,37612.70013.600 13.510USD 32,100 15.00
2024-12-04BUY13212.96013.025 13.018USD 1,718 15.16
2024-12-03BUY19812.80013.620 13.538USD 2,681 15.22
2024-11-19BUY39613.10013.520 13.478USD 5,337 16.01
2024-11-18BUY13213.45014.145 14.076USD 1,858 16.10
2024-11-12BUY25616.02017.503 17.355USD 4,443 16.10
2024-11-11BUY6417.27017.500 17.477USD 1,119 16.01
2024-11-11BUY6417.27017.500 17.477USD 1,119 16.01
2024-11-07BUY31515.58017.190 17.029USD 5,364 16.05
2024-11-07BUY31515.58017.190 17.029USD 5,364 16.05
2024-10-23BUY12415.61015.910 15.880USD 1,969 16.08
2024-10-23BUY12415.61015.910 15.880USD 1,969 16.08
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGEM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1991,7130453,13720.2%
2025-09-1829,90964374,3228.0%
2025-09-1729,113561152,08119.1%
2025-09-1641,7652156,36626.7%
2025-09-1569,037556213,45032.3%
2025-09-1276,0840383,50219.8%
2025-09-1166,615867581,52011.5%
2025-09-1055,0970308,72517.8%
2025-09-09106,4910278,73338.2%
2025-09-0844,9790172,18226.1%
2025-09-0592,5842,960314,97529.4%
2025-09-04218,97713,252745,97129.4%
2025-09-0359,5350162,54436.6%
2025-09-0230,2150107,25628.2%
2025-08-2928,9550102,69028.2%
2025-08-2839,008089,89543.4%
2025-08-2750,5440153,48132.9%
2025-08-2638,6843378,65710.2%
2025-08-2517,620058,53130.1%
2025-08-2273,1000173,43542.1%
2025-08-2127,559085,31232.3%
2025-08-2037,739091,41841.3%
2025-08-1937,960083,52645.4%
2025-08-1877,2120180,13542.9%
2025-08-1537,9960114,06733.3%
2025-08-1415,1790186,7068.1%
2025-08-1325,9030130,51119.8%
2025-08-1244,9730119,05337.8%
2025-08-1141,962128103,18340.7%
2025-08-0867,3042,573153,71443.8%
2025-08-0780,102176173,93646.1%
2025-08-0621,373051,51641.5%
2025-08-0522,741058,65038.8%
2025-08-0426,114093,27628.0%
2025-08-0138,24057976,87449.7%
2025-07-3135,0275868,86450.9%
2025-07-3080,5000739,89910.9%
2025-07-2958,3939130,45944.8%
2025-07-2827,557046,54859.2%
2025-07-2521,73617636,20960.0%
2025-07-2454,73018130,09542.1%
2025-07-2377,9670133,95558.2%
2025-07-2249,802089,67155.5%
2025-07-2127,480040,11268.5%
2025-07-1829,606050,25158.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy